共 50 条
- [26] Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma: Is It Time to Consider CAR-T for All JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (12): : 1764 - 1766
- [29] NICE approves routine NHS use of CAR-T for diffuse large B-cell lymphoma LANCET ONCOLOGY, 2023, 24 (03): : 208 - 208